- Home
- BTU vs NEO Comparison
BTU vs NEO Comparison
Compare BTU & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTU
- NEO
- Stock Information
- Founded
- BTU 2016
- NEO 2001
- Country
- BTU United States
- NEO United States
- Employees
- BTU N/A
- NEO N/A
- Industry
- BTU Coal Mining
- NEO Precision Instruments
- Sector
- BTU Energy
- NEO Health Care
- Exchange
- BTU Nasdaq
- NEO Nasdaq
- Market Cap
- BTU 2.3B
- NEO 2.3B
- IPO Year
- BTU N/A
- NEO 1999
- Fundamental
- Price
- BTU $19.59
- NEO $14.18
- Analyst Decision
- BTU Strong Buy
- NEO Strong Buy
- Analyst Count
- BTU 5
- NEO 10
- Target Price
- BTU $28.40
- NEO $20.56
- AVG Volume (30 Days)
- BTU 2.9M
- NEO 1.2M
- Earning Date
- BTU 02-06-2025
- NEO 02-18-2025
- Dividend Yield
- BTU 1.53%
- NEO N/A
- EPS Growth
- BTU N/A
- NEO N/A
- EPS
- BTU 3.78
- NEO N/A
- Revenue
- BTU $4,348,600,000.00
- NEO $644,118,000.00
- Revenue This Year
- BTU N/A
- NEO $12.98
- Revenue Next Year
- BTU N/A
- NEO $9.94
- P/E Ratio
- BTU $5.17
- NEO N/A
- Revenue Growth
- BTU N/A
- NEO 12.06
- 52 Week Low
- BTU $17.73
- NEO $12.13
- 52 Week High
- BTU $29.94
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- BTU 42.18
- NEO 40.28
- Support Level
- BTU $18.15
- NEO $13.93
- Resistance Level
- BTU $19.10
- NEO $16.18
- Average True Range (ATR)
- BTU 0.76
- NEO 1.13
- MACD
- BTU 0.16
- NEO -0.33
- Stochastic Oscillator
- BTU 51.48
- NEO 29.37
About BTU Peabody Energy Corporation
Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. Powder River Basin segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan and other regions.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.